Property:Appraisal clinical question

From Cancer Guidelines Wiki

This is a property of type Page. It links to pages that use the form Clinical question.

Pages using the property "Appraisal clinical question"

Showing 25 pages using this property.

View (previous 25 | next 25) (20 | 50 | 100 | 250 | 500)

1
1999 +What is the optimal systemic therapy for stage IV inoperable NSCLC?  +
1999 2 +What is the optimal systemic therapy regimen for patients with poor performance status for treatment of stage IV inoperable NSCLC?  +
1999 3 +What is the optimal systemic therapy regimen for elderly patients for treatment of stage IV inoperable NSCLC?  +
2
2008 +Cancer chemotherapy medication safety guidelines  +
2009 +Cancer chemotherapy medication safety guidelines  +
2012 2 +Cancer chemotherapy medication safety guidelines  +
2013 2 +Cancer chemotherapy medication safety guidelines  +
2014 5 +Cancer chemotherapy medication safety guidelines  +
2014 6 +Do patients who are referred to fertility specialists experience less decisional conflict?  +
?
?ukaszewicz-Zajac M, Mroczko B, Koz?owski M, Nikli?ski J, Lauda?ski J, Szmitkowski M 2010 +Are there useful biomarkers to detect and improve the diagnosis of neoplasia in patients with or without BO?  +
A
AB Ogunrombi, UU Onakpoya, U Ekrikpo, AS Aderibigbe, OA Aladesuru 2014 +What is the optimal management of malignant pleural effusions?  +
ASHP Council on Professional Affairs 2002 +Cancer chemotherapy medication safety guidelines  +
Abacioglu U, Caglar H, Atasoy BM, Abdulloev T, Akgun Z, Kilic T 2010 +What is the role of stereotactic radiosurgery in the treatment of brain metastases?  +
Abatzoglou S, Turcotte RE, Adoubali A, Isler MH, Roberge D 2010 +What are the factors influencing the extent of surgery in BSTTs?  +
Abatzoglou S, Turcotte RE, Adoubali A, Isler MH, Roberge D 2010 2 +What is the evidence for radiotherapy in limb and extremity soft tissue sarcoma in terms of local recurrence, survival and limb salvage?  +
Abbas AE, Deschamps C, Cassivi SD, Allen MS, Nichols FC 3rd, Miller DL, et al 2004 +Are there any treatments that prevent progression of BO to cancer?  +
Abbott AM, Habermann EB, Parsons HM, Tuttle T, Al-Refaie W 2012 +What is the role of prognostic factors in management of BSTTs?  +
Abd-Alazeez M, Ahmed HU, Arya M, Charman SC, Anastasiadis E, Freeman A, et al 2014 +In men with suspected prostate cancer whose initial TRUS biopsy is negative, what should be the next investigation(s)?  +
Abd-Alazeez M, Ahmed HU, Arya M, Charman SC, Anastasiadis E, Freeman A, et al 2014 2 +In men with suspected prostate cancer whose initial TRUS biopsy is negative, what should be the next investigation(s)?  +
Abdel-Rahman O, ElHalawani H 2016 +What is the optimal first-line chemotherapy regimen in patients with stage IV inoperable NSCLC?  +
Abe S, Tokizaki T, Miki Y, Tateishi A, Ogawa K, Nakano H, et al 2005 +What is the role of regional chemotherapy in BSTTs?  +
Abela JE, Going JJ, Mackenzie JF, McKernan M, O'Mahoney S, Stuart RC 2008 2 +What is the optimal tissue sampling at endoscopy for diagnosis of BO?  +
Abellan JF, Lamo de Espinosa JM, Duart J, Patiño-García A, Martin-Algarra S, Martínez-Monge R, et al 2009 +Does referral to a specialist centre improve outcomes?  +
Abellan JF, Lamo de Espinosa JM, Duart J, Patiño-García A, Martin-Algarra S, Martínez-Monge R, et al 2009 2 +What is the impact of delay in referral to a specialist centre in BSTTs?  +
Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al 2011 +In people at risk of lung cancer, does population based screening with chest radiography reduce mortality?  +